BEAMSTART Logo

The World’s First Crispr Drug Gets a Slow Start

Wired LogoWired15h ago

The World’s First Crispr Drug Gets a Slow Start - Wired

Quick Summary:

The first medical treatment to use Crispr gene editing has been on the market for a year.

Its complexity means few patients in the US have received it yet.

Stephan Grupp, section chief of cellular therapy and transplant at the Children’s Hospital of Philadelphia, says doctors will likely need to secure a single case agreement from insurers on behalf of their patients.

More Pictures

The World’s First Crispr Drug Gets a Slow Start - Wired (Picture 1)The World’s First Crispr Drug Gets a Slow Start - Wired (Picture 2)The World’s First Crispr Drug Gets a Slow Start - Wired (Picture 3)The World’s First Crispr Drug Gets a Slow Start - Wired (Picture 4)The World’s First Crispr Drug Gets a Slow Start - Wired (Picture 5)

or

Article Details

Author / Journalist: Emily Mullin

Category: TechnologyEconomy

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-12-23 @ 11:30:00 (15 hours ago)

News Timezone: GMT +8:00

News Source URL: wired.com

Language: English

Article Length: 2488 words

Reading Time: 14 minutes read

Sentences: 118 lines

Sentence Length: 22 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Wired

News ID: 24595696

View Article Analysis

About Wired

Main Topics: TechnologyEconomy

Official Website: wired.com

Update Frequency: 11 posts per day

Year Established: 1993

Headquarters: United States

News Last Updated: 9 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #111

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "The World’s First Crispr Drug Gets a Slow Start" has 2488 words across 118 sentences, which will take approximately 11 - 21 minutes for the average person to read.

Which news outlet covered this story?

The story "The World’s First Crispr Drug Gets a Slow Start" was covered 15 hours ago by Wired, a news publisher based in United States.

How trustworthy is 'Wired' news outlet?

Wired is a fully independent (privately-owned) news outlet established in 1993 that covers mostly technology and economy news.

The outlet is headquartered in United States and publishes an average of 11 news stories per day.

It's most recent story was published 9 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #24595696
  • URL: https://beamstart.com/news/the-worlds-first-crispr-drug-17349540431473

More News from Wired

Latest Jobs

More Technology News

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

Our Company

© Copyright 2024 BEAMSTART. All Rights Reserved.